Monoclonal Antibodies against EGFRvIII Are Tumor Specific and React with Breast and Lung Carcinomas and Malignant Gliomas

Cancer Research

Volumn 55, Issue 14, 1995, Pages 3140-3148

  Wikstrand, Carol J ^a   Hale, Laura P ^a   Batra, Surinder K ^a   Hill, M Leslie ^a   Humphrey, Peter A ^b   Kurpad, Shekar N ^a   McLendon, Roger E ^a   Moscatello, David ^c   Pegram, Charles N ^a   Reist, Craig J ^a   Traweek, S Thomas ^a   Wong, Albert J ^c   Zalutsky, Michael R ^a   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BREAST CARCINOMA; CANCER IMMUNOTHERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; BREAST NEOPLASMS; FEMALE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KINETICS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029025332     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA, 84: 6899–6903, 1987.
2. Humphrey, P. A., Wong, A. J., Vogelstein, B., Friedman, H. S., Werner, M. H., Bigner, D. D., and Bigner, S. H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res., 48: 2231–2238, 1988.
3. Yamazaki, H., Ohba, Y., Tamaoki, N., and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81: 773–779, 1990.
4. Sugawa, N., Ekstrand, A. J., James, C. D., and Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl. Acad. Sci. USA, 87: 8602–8606, 1990.
5. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309–4313, 1992.
6. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. D., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965–2969, 1992.
7. Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., and Bigner, D. D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Nat. Acad. Sci. USA, 87: 4207–4211, 1990.
8. Garcia de Palazzo, I., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53: 3217–3220, 1993.
9. Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., and Bigner, D. B. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res., 50: 8017–8022, 1990.
10. Gullick, W. J., Downward, J., Parker, P. J., Whittle, N., Kris, R., Schlessinger, J., Ullrich, A., and Waterfield, M. D. The structure and function of the epidermal growth factor receptor studied by using anti-synthetic peptide antibodies. Proc. R. Soc. Lond. B Biol. Sci., 2256: 127–134, 1985.
11. Wikstrand, C. J., Stanley, S. D., Humphrey, P. A., Pegram, C N., Archer, G. E., Kurpad, S., Shibuya, M., and Bigner, D. D. Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas. J. Neuroimmunol., 46: 165–174, 1993.
12. Bernatowicz, M. S., and Matsuada G. R. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional cross-linking reagent. Anal. Biochem., 155: 95–102, 1986.
13. Wikstrand, C. J., Bourdon, M. A., Pegram, C N., and Bigner, D. D. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin: gliomas, neuroblastomas, and melanomas. J. Neuroimmunol., 3: 43–62, 1982.
14. Wikstrand, C. J., McLendon, R. E., Bullard, D. E., Fredman, P., Svennerholm, L., and Bigner, D. D. Production and characterization of two human glioma xenograft localizing monoclonal antibodies (MAbs). Cancer Res., 46: 5933–5940, 1986.
15. He, X., Archer, G. E., Wikstrand, C. J., Morrison, S. L., Zalutsky, M. R., Bigner, D. D., and Batra, S. K. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin. J. Neuroimmunol., 52: 127–137, 1994.
16. McPherson, G. A. A practical computer-based approach to the analysis of radioligand experiments. Comput. Methods Programs Biomed., 17: 107–114, 1983.
17. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77–89, 1984.
18. Bjerkvig, R., Engebraaten, O., Laerum, O. D., Fredman, P., Svennerholm, L., Vrionis, F. D., Wikstrand, C. J., and Bigner, D. D. Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. Cancer Res., 51: 4643–4648, 1991.
19. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain rumours of glial origin. Nature (Lond.), 313: 144–147, 1985.
20. Wikstrand, C. J., Friedman, H. S., and Bigner, D. D. Medulloblastoma cell-substrate interaction in vitro. Invasion Metastasis, 77: 310–324, 1991.
21. Johnsson, B., Lofas, S., and Lindqvist, G. Immobilization of proteins to a carboxy-methyldcxtran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem., 198: 268–277, 1991.
22. Calakos, N., Bennett, M. K., Peterson, K. E., and Scheller, R. H. Protein-protein interactions contributing to the specificity of intracellular vesicular trafficking. Science (Washington DC), 263: 1146–1149, 1994.
23. O'Shannessy, D. J., Brigham-Burke, M., Soneson, K. K., Hensley, P., and Brooks, I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of non-linear least squares analysis methods. Anal. Biochem., 272: 457–468, 1993.
24. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156–159, 1987.
25. Pruss, R. M., and Herschman, H. R. Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. Proc. Natl. Acad. Sci. USA, 14: 3918–3921, 1977.
26. Prabhu, S. C., Batra, S. K., Wikstrand, C. J., Shibuya, M., and Bigner, D. D. Transfection of human epidermal growth factor receptor mutant cDNA into an NIH Swiss 3T3 variant, NR6, cell line: integration, expression, and characterization. Mol. Biol. Cell, 4: 21A, 1993.
27. Ullrich, A., Coussens, L, Hayflick, J. S., et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418–425, 1984.
28. Batra, S. K., Kern, H. F., Worlock, A. J., Metzgar, R. S., and Hollingsworth, M. A. Transfection of the human Mucl mucin gene into a poorly differentiated human pancreatic tumor cell line, Panel: integration, expression, and ultrastructural changes. J. Cell Science, 100: 891–894, 1991.
29. Malmborg, A. D., Michaelsson, A. C., Ohlin, M., Jansson, B., and Borrebaeck, C. A. Real time analysis of antibody-antigen reaction kinetics. Scand. J. Immunol., 35: 643–650, 1992.
30. Karlsson, R., Michaelsson, A., and Mattsson, L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods, 145: 229–240, 1991.
31. Reeves, J. R., Cooke, T. G., Fenton-Lee, D., McNicol, A. M., Ozanne, B. W., Richards, R. C., and Walsh, A. Localization of EGF receptors in frozen tissue sections by antibody and biotinylated EGF-based techniques. J. Histochem. Cytochem., 42: 307–314, 1994.
32. Marti, U., and Gebhardt, R. Acinar heterogeneity of the epidermal growth factor receptor in the liver of male rats. Eur. J. Cell Biol., 55: 158–164, 1991.
33. Foresta, C., Caretto, A., Varotto, A., Rossato, M., and Scandellari, C. Epidermal growth factor receptors (EGFR) localization in human testis. Arch. Androl., 27: 17–24, 1991.
34. Owens, O. J., and Leake, R. E. Epidermal growth factor receptor in normal ovaries and benign ovarian tumors. Eur. J. Obstet. Gynecol. Reprod. Biol., 47: 229–233, 1992.
35. Zeder-Lutz, G., Altschuh, D., Geysen, H. M., Trifilieff, E., Sommermeyer, G., and van Regenmortel, M. H. V. Monoclonal antipeptide antibodies: affinity and kinetic rate constants measured for the peptide and the cognate protein using a biosensor technology. Mol. Immunol., 30: 145–155, 1993.
36. Kaufman, E. N., and Jain, R. K. Effect of bivalent interaction upon apparent antibody affinity: experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays. Cancer Res., 52: 4157–4167, 1992.
37. Fujimori, K., Covell, D. C., Fletcher, J. E., and Weinstein, J. N. A modeling analysis of the global and microscopic distribution of IgG, F(ab′)2, and Fab in tumors. Cancer Res., 49: 5656–5663, 1989.
38. Fujimori, K., Fisher, D. R., and Weinstein, J. N. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution. Cancer Res., 51: 4821–4827, 1991.
39. Van Osdol, W., Fujimori, K., and Weinstein, J. N. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a “binding site barrier.” Cancer Res., 57: 4776–4784, 1991.
40. Langmuir, V. K., Mendonca, H. L., and Woo, D. V. Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids. Cancer Res., 52: 4278–4784, 1992.
41. Nishikawa, R., Ji, X-D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H-J. S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91:7727–7731, 1994.
42. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin. Cancer Res., in press, 1995.
43. Modjtahedi, H., Eccles, S., Sandle, J., Box, G., Titley, J., and Dean, C. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res., 54: 1695–1701, 1994.
44. Vitetta, E. S., and Uhr, J. W. Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy. Cancer Res., 54: 5301–5309, 1994.